Nu-Med Plus Announces Filing of U.S. Provisional Patent Application for Nitric Oxide in Aqueous Solution for Wound Care Treatment
03. November 2020 07:30 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide in the medical...
Patent Issued for Single-Use or Short-Term Nitric Oxide Delivery Device
28. Juli 2020 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, July 28, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide delivery in the...
Patent Issuance Allowed for Single-Use or Short-Term Nitric Oxide Delivery Device
28. Mai 2020 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, May 28, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide delivery in the...
Nu-Med Plus Closely Monitoring Outcomes on Two New Human Clinical Trials Using Inhaled Nitric Oxide in Treatment of COVID-19
25. März 2020 06:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, March 25, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide in the medical...
Patent filed for Nitric Oxide Delivery Device that is comparable to inhalers for single or short-term usage
07. Januar 2020 06:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), National Investment Bankers Association (NIBA) presenter Nu-Med Plus, Inc., a medical device development company...
Nu-Med Plus Presents at the 147th National Investment Banking Association Conference on November 12-13, 2019 in New York City
03. Dezember 2019 05:30 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), announced today that the Company attended and presented at the 147th National Investment Banking Association (NIBA)...
Nu-Med Plus, Inc. Fast-Tracked Development Plan for Nitric Oxide Delivery Device Gaining Momentum
23. Oktober 2019 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology along with innovative applications in the...
Nu-Med Plus Accelerates FDA Submission in Light of Patent Ruling
10. September 2019 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device developer of new nitric oxide delivery technology announced that it will be accelerating the FDA...
Nu-Med Plus, Inc. Approaches Milestone FDA Application for New Nitric Oxide Medical Device Approval
18. Juni 2019 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, June 18, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology along with innovative applications in the...
Nu-Med Plus Reports Spike in International Interest from Physicians, Distributors, and Potential Strategic Partners
03. April 2019 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, April 03, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, reports an increase in strategic...